Cargando…

Patterns of Fluoroquinolone Prescribing at a Tuberculosis Hospital

BACKGROUND: Texas Center for Infectious Disease is a hospital that specializes in the treatment of tuberculosis (TB). Fluoroquinolones (FQ) play a vital role in the management of TB. FQ are used in patients with drug-resistant TB, intolerance to first line TB medications, extensive disease, elevated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kizilbash, Quratulain, Meyer, Vanessa, Anozie, Chizoba, Vasquez, Adriana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631105/ http://dx.doi.org/10.1093/ofid/ofx163.1795

Ejemplares similares

801. Emergence of Multi-Drug Resistance Tuberculosis During the Treatment Course of Pan-Susceptible TB: A Case Series
por: Ford, Mary, et al.
Publicado: (2018)

Strategies for Successful Treatment of Active Tuberculosis in the Setting of DRESS on RIPE
por: Kizilbash, Quratulain, et al.
Publicado: (2018)

1008. The Reduction of Fluoroquinolone Prescribing in Rural Vermont Hospitals
por: Smith, Lindsay, et al.
Publicado: (2019)

Reduction in Nontuberculous Mycobacteria at a Tuberculosis Hospital Following a Quality Assurance Intervention
por: Kizilbash, Quratulain, et al.
Publicado: (2017)

Mechanical complication of endobronchial tuberculosis
por: Kizilbash, Quratulain Fatima
Publicado: (2015)

2092. Acceptability and Effectiveness of Implementation Strategies on Fluoroquinolone (FQ) Prescribing
por: Suda, Katie J, et al.
Publicado: (2019)

201. Healthcare utilization outcomes of patients prescribed fluoroquinolones on discharge from the hospital to nursing homes
por: Lantz, Tyler L, et al.
Publicado: (2020)

1863. Antibiotic Prescribing Before and After an FDA Boxed Warning on Fluoroquinolones in 2016
por: Willis, Zachary, et al.
Publicado: (2018)

1009. Measuring the quality of fluoroquinolone prescribing in hospitals: results from the Emerging Infections Program Hospital Prevalence Survey Antimicrobial Quality Assessment
por: Magill, Shelley S, et al.
Publicado: (2019)

1572. Impact of a Multicenter Fluoroquinolone Stewardship Collaboration on Prescribing Trends over Five Years
por: Olson, Kelsey, et al.
Publicado: (2022)

70. Impact of Fluoroquinolone Susceptibility Suppression on Discharge Prescribing for Acute Uncomplicated Cystitis
por: Hayden, Dillon, et al.
Publicado: (2020)

20. Fluoroquinolone and Overall Outpatient Antibiotic Prescribing Trends in Adults, 2011 to 2018
por: Gouin, Katryna A, et al.
Publicado: (2020)

183. Alerting and Education via the Electronic Health Record (EHR) Decreases Inappropriate Fluoroquinolone prescribing in the Emergency Department of a Large Integrated Hospital Network
por: Davidson, Lisa, et al.
Publicado: (2018)

Prevalence and Correlates of “High Dose” Antipsychotic Prescribing: Findings from a Hospital Audit
por: Adesola, AO, et al.
Publicado: (2013)

221. Save the Quinolones! Impact of a Non-Restrictive Fluoroquinolone Reduction Initiative on Antibiotic Resistance at an Urban Teaching Hospital
por: Smoke, Steven, et al.
Publicado: (2018)

228. Fluoroquinolone Prescribing for Diabetic Foot Infections following an FDA Drug Safety Communication for Aortic Aneurysm Risk
por: Li, Catherine, et al.
Publicado: (2020)

The Association of Antibiotic Stewardship With Fluoroquinolone Prescribing in Michigan Hospitals: A Multi-hospital Cohort Study
por: Vaughn, Valerie M, et al.
Publicado: (2019)

Impact of a Targeted Fluoroquinolone Restriction on Antimicrobial Usage at Two Community Hospitals
por: Borkowski, Jaime, et al.
Publicado: (2017)

158. Impact of Fluoroquinolone Cascade Reporting of Urine Samples on Antibiotic Prescribing Rates in a Network of Urgent Care Clinics
por: Weichman, Brittani, et al.
Publicado: (2021)

Local Nursing Home Prescribing Patterns and Psychoactive Prescribing in Assisted Living
por: Thomas, Kali, et al.
Publicado: (2020)

Establishing Antibiotic Stewardship Programs in Rural Hospitals to Decrease Fluoroquinolone Prescribing: The Vermont Experience
por: Smith, Lindsay M., et al.
Publicado: (2021)

Multi-drug resistant tuberculous spondylitis: A review of the literature
por: Kizilbash, Quratulain Fatima, et al.
Publicado: (2016)

129. Antimicrobial Stewardship Intervention Bundle Decreases Fluoroquinolone Prescribing for Urinary Tract Infection in Urgent Care and Primary Care Clinics
por: Cubillos, Ashley L, et al.
Publicado: (2020)

1106. Assessment of Fluoroquinolone Appropriateness for Hospitalized Patients with Asymptomatic Bacteriuria and Cystitis: A Multi-Hospital Cohort Study
por: Gandhi, Tejal N, et al.
Publicado: (2019)

1787. County Level Association Between the Rate of Fluoroquinolone-Resistance Gram Negative Bacteria and Fluoroquinolone Utilization in Kansas
por: Fulmer, Robert D, et al.
Publicado: (2022)

Evaluation of the appropriate use of commonly prescribed fluoroquinolones and the risk of dysglycemia
por: Kabbara, Wissam K, et al.
Publicado: (2015)

2225. Are Fluoroquinolones or Macrolides Better for Treating Legionella Pneumonia? A Systematic Review and Meta-Analysis
por: Jasper, Annie S, et al.
Publicado: (2019)

Improvement of Gram-negative Susceptibility to Fluoroquinolones After Implementation of a Pre-Authorization Policy for Fluoroquinolone Use: A Decade-Long Experience
por: Lee, Rachael A, et al.
Publicado: (2017)

PS74. Antidepressant prescribing patterns and adherence to treatment in one tertiary care university hospital
por: Ahn, So Hyun, et al.
Publicado: (2016)

1136. Antifungal Prescribing Patterns among Hospitalized Children in the United States: Are There Opportunities for Antifungal Stewardship?
por: Eguiguren, Lourdes, et al.
Publicado: (2019)

Impact of Education on Fluoroquinolone Use in Uncomplicated Cystitis
por: Ferren, Ryan, et al.
Publicado: (2017)

1842. Fluoroquinolone Usage Reduction in the Outpatient Setting
por: Mang, Norman, et al.
Publicado: (2018)

2077. Fluoroquinolone Usage Reduction in the Outpatient Setting
por: Lin, Kevin, et al.
Publicado: (2019)

1115. Use of a Fluoroquinolone (FQ) vs. a Non-Fluoroquinolone (Non-FQ)-Based Antibiotic Regimen in the Treatment of Acute, Uncomplicated Diverticulitis
por: Mourani, Jessyca, et al.
Publicado: (2018)

2184. Effect of Adjusted CLSI Breakpoints on Center-wide Fluoroquinolone Susceptibilities for Enterobacteriaceae and Pseudomonas aeruginosa: Is It Time to Restrict Empiric Fluoroquinolone Use?
por: Sansom, Sarah, et al.
Publicado: (2019)

855. Impact of FDA Black Box Warning on Fluoroquinolone and Alternative Antibiotic Use in Southeastern US Hospitals
por: Yarrington, Michael, et al.
Publicado: (2018)

236. Incorporating Clinical Guidance into Computerized Prescriber Order Entry May Reduce Fluoroquinolone Utilization for the Treatment of Diverticulitis at a Rural Community Health System
por: Tirupathi, Raghavendra, et al.
Publicado: (2020)

The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019
por: Pranger, A. D., et al.
Publicado: (2019)

Resistance patterns, prevalence, and predictors of fluoroquinolones resistance in multidrug resistant tuberculosis patients
por: Ahmad, Nafees, et al.
Publicado: (2015)

2253. Hospitalist Antibiotic Prescribing Patterns by Hour and Weekday
por: Gray, Joshua H, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1kkbd0jbh1kqg4na5i3582281a